New products and changes introduced over the last week include the partnership announced between Abacus Group and Imagineer Technology Group that will host the latter’s software platform in the former’s private cloud and Paulson & Co. opened two new share classes for its Advantage funds.
In addition, Invesco PowerShares announced a special dividend for PowerShares QQQ (QQQ).
Here are the latest developments of interest to advisors:
Paulson & Co. Announces Two Additional Share Classes for Advantage Funds
Paulson & Co. has announced that it is now offering two additional share classes for its Advantage funds that offer different liquidity terms for different fees.
Paulson Advantage L.P. and Paulson Advantage Ltd. are now available in B shares that permit monthly withdrawals on 60 days’ notice instead of the once-a-quarter withdrawals permitted in existing shares; the B shares, however, carry a 2% management fee instead of the existing shares’ 1.5%. C shares permit only once-a-year withdrawals but the management fee is only 1%.
Top 5 Railroad Companies For 2015: Chimerix Inc (CMRX)
Chimerix, Inc., incorporated on April, 07, 2000, is a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need. Its lipid technology has given rise to two clinical-stage compounds, CMX001 and CMX157, which have demonstrated the potential for enhanced antiviral activity and safety in convenient, orally administered dosing regimens.
CMX001 is an orally administered drug that utilizes its lipid technology to deliver intracellular concentrations of a potent antiviral compound, cidofovir-diphosphate (CDV-PP). Following oral dosing, CMX001 is absorbed through the gut, remains intact in the plasma, and is readily taken up by and delivered into cells. Once inside cells, CMX001 is converted into CDV-PP, which acts as an alternative substrate in a replicating virus. CMX001 is similar to the drug cidofovir in that both drugs are converted into CDV-PP once inside cells. Although cidofovir is approved for administration in an intravenous formulation, Vistide, it requires a plasma concentration to deliver a therapeutic level of cidofovir into cells and its use is limited due to the risk of kidney damage.
CMX157, Its second clinical stage compound, is an oral nucleotide compound in Phase 1 development for the treatment of human immunodeficiency virus (HIV) infection. In July 2012, the Company granted Merck an exclusive worldwide license to develop and commercialize CMX157 for all human uses. Merck is responsible for all development and marketing activities for CMX157 on a worldwide basis.
Advisors' Opinion:- [By Ben Levisohn]
Biotech companies that are most likely to benefit because they are “Ahead in clinical development and/or have established relationships with [the Biomedical Advanced Research and Development Authority, or] BARDA which may facilitate getting a contract” include GlaxoSmithKline (GSK), NewLink Genetics (NLNK), Johnson & Johnson (JNJ) and Chimerix (CMRX). Kantor includes Tekmira�(TKMR) and Sarepta (SRPT) among “companies with viable programs” that are “moving forward and likely to attract additional funding.”
Top Prefered Companies To Buy For 2014: Neuralstem Inc (CUR)
Neuralstem, Inc., incorporated in 1997, is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs. The Company has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area of neural stem cell research. The Company's focus is the development of methods to generate replacement cells from neural stem cells.
In October of 2011, the Company announced that after reviewing safety data from the first 12 patients, the FDA granted approval for the trial to advance to transplanting patients in the cervical (upper back) region for the last six patients in the trial. As of December 31, 2011, the Company had treated 14 patients. In February of 2011, the Company commenced a Phase Ia clinical trial of its drug compound, NSI-189, which is being developed for the treatment of depressive disorder and other psychiatric indications. In October of 2011, the Company completed the Phase Ia portion of the trial. In December of 2011, the Company received approval from the FDA to commence the Phase Ib portion of the trial.
During the year ended December 31, 2011, the Company was selected as the primary subcontractor for the United States Department of Defense (DOD) contract to develop human neural stem cell technology for the treatment of cancerous brain tumors. The Company commenced work on the project in May 2011. The Company has developed and patented a series of small molecule compounds (low molecular weights organic compounds which can efficiently cross the blood/brain barrier).
Advisors' Opinion:- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By John Udovich]
Summer and the slow news for the market that usually comes with it�is over with and both stem cell researchers or small� cap stem cell stocks like Advanced Cell Technology, Inc (OTCBB: ACTC), Neuralstem, Inc (NYSEMKT: CUR), NeoStem Inc (NASDAQ: NBS), International Stem Cell Corp (OTCMKTS: ISCO)�and BioRestorative Therapies (OTCBB: BRTX) having news for investors and traders alike. Consider the following:
Top Prefered Companies To Buy For 2014: Antofagasta PLC (ANTO)
Antofagasta plc (Antofagasta) is a Chile-based copper mining company with interests in transport and water distribution. The Company operates in three segments: Mining, Transport and Water. Antofagasta is a holding company that operates through its subsidiaries, associates and joint ventures. The principal activities of the Company are copper mining (including exploration and development), the transportation of freight by rail and road and the distribution of water. Its mining operations produce copper with by-products of gold, molybdenum and silver. Its activities are mainly concentrated in Chile. The Company�� segments include Los Pelambres, Esperanza, El Tesoro, Michilla, Antucoya, Exploration and evaluation, Railway and other transport services, Water concession, and Corporate and other items. Advisors' Opinion:- [By Jonathan Morgan]
Anglo American and Rio Tinto retreated 2.8 percent to 1,421.5 pence and 2.4 percent to 2,740 pence, respectively. Lonmin Plc, the world�� third-largest platinum producer, slipped 3.2 percent to 287.6 pence. Antofagasta Plc (ANTO), the Chilean copper producer, declined 1.2 percent to 911 pence.
- [By Namitha Jagadeesh]
British American Tobacco Plc and Imperial Tobacco Group Plc (IMT) each lost at least 1.5 percent as American peer Philip Morris International Inc. forecast 2014 profit growth below its long-term target. Antofagasta Plc (ANTO) and Vedanta Resources Plc (VED) followed miners lower, sliding at least 2 percent. Johnson Matthey Plc (JMAT) gained 3.9 percent after posting better-than-forecast profit and raising its dividend.
- [By Sarah Jones]
Vedanta Resources slumped 6.5 percent to 1,026 pence as copper tumbled on the London Metal Exchange to its lowest price since July 2010. Antofagasta Plc (ANTO), the copper producer controlled by Chile�� Luksic family, slid 3 percent to 813 pence and Anglo American Plc (AAL) lost 4 percent to 1,297.5 pence.
- [By Sarah Jones]
Rio Tinto, the world�� second-largest mining company, fell 2.7 percent to 2,959.5 pence. Anglo American dropped 2.6 percent to 1,606 pence and Antofagasta Plc (ANTO), which mines for copper in Chile, retreated 3.9 percent to 916 pence.
Top Prefered Companies To Buy For 2014: Methode Electronics Inc (MEI)
Methode Electronics, Inc., incorporated on April 27, 1966, is a manufacturer of component and subsystem devices with manufacturing, designs and testing facilities in China, Egypt, Germany, India, Lebanon, Malta, Mexico, the Philippines, Singapore, Switzerland, the United Kingdom and the United States. The Company operates in four segments: automotive, interconnect, power products, and other. The Company designs, manufactures and markets devices employing electrical, radio remote controls, electronic, wireless and sensing technologies. The Company's components are found in the primary end markets of the aerospace, appliance, automotive, construction, consumer and industrial equipment, communications, including information processing and storage, networking equipment, wireless and terrestrial voice/data systems, rail and other transportation industries.
Automotive
The Company�� automotive segment supplies electronic and electro-mechanical devices and related products to automobile original equipment manufacturers, (OEMs), either directly or through their tiered suppliers. The Company's products include control switches for electrical power and signals, connectors for electrical devices, integrated control components, switches and sensors that monitor the operation or status of a component or system, and packaging of electrical components.
Interconnect
The interconnect segment provides a variety of copper and fiber-optic interconnect and interface solutions for the aerospace, appliance, commercial, computer, construction, consumer, material handling, medical, military, mining, networking, storage, and telecommunications markets. Solutions include conductive polymers, connectors, custom cable assemblies, industrial safety radio remote controls, optical and copper transceivers, personal computer and express card packaging and terminators, solid-state field effect interface panels, and thick film inks. Services include the design and installation of f! iber optic and copper infrastructure systems, and manufacturing active and passive optical components.
Power products
The power products segment manufactures braided flexible cables, current-carrying laminated bus devices, custom power-product assemblies, high-current low voltage flexible power cabling systems and powder coated bus bars that are used in various markets and applications, including aerospace, computers, industrial and power conversion, inverters and battery systems, insulated gate bipolar transistor solutions, military, telecommunications, and transportation.
Other
The other segment includes a designer and manufacturer of magnetic torque sensing products, and independent laboratories that provide services for qualification testing and certification, and analysis of electronic and optical components.
Advisors' Opinion:- [By John Udovich]
On Thursday, small cap electronics stock Methode Electronics Inc (NYSE: MEI) soared 43.07% after beating earnings expectations and boasting its guidance. However, the stock sank around 10.5% the day before the Thursday morning earnings report came out. So was the earnings report and guidance the start of a rally or just a dead cat bounce for investors?
- [By gurujx]
Methode Electronics Inc. (MEI): CFO Douglas A. Koman Sold 60,000 Shares
CFO�Douglas A. Koman�sold 60,000 shares of MEI stock on 12/31/2013 at the average price of $34.13. Douglas A. Koman owns at least 203,418 shares after this. The price of the stock has increased by 3.34% since.
- [By Ben Levisohn]
Methode Electronics (MEI) has gained 33% to 23.43 today after the company reported better revenue and profit numbers than even the most positive analyst had expected. It also raised its guidance well above previously announced levels.
AFP/Getty ImagesThe component maker reported a profit of 36 cents a share, above forecasts for 21 cents, and sales of $167.3� million dollars, beating forecasts for $148.5 million. It also said that it expected full-year earnings to fall in a range of $1.40 to $1.60, well above analyst forecasts for $1.05.
Baird’s David Leiker and Joseph Vruwink call it a “breakout quarter.” They write:
Upside across all segments and all line items with 41% revenue surge coming in 10% above expectations. One-half of the beat from revenue with balance split among gross margin, SGA and lower tax rate. Launches going very well, continuing the performance seen in April quarter.
Automotive results accounted for two-thirds of the upside at the pre-tax line. The upside was spread between stronger revenues ($0.03), gross profits ($0.03) and expense control ($0.02). While North American sales improved 86% on the K2XX launch (we assumed 56% growth), international revenues also contributed favorably with 26% growth in Europe (new business and Ford�� (F) recovery) and 22% growth in Asia.
Competitor AVX Corp. (AVX) has gained 1.1% to $12.96, while Molex (MOLX) has dropped 0.2% to $29.28 and Amphenol (APH) has ticked up 0.3% to $76.32.
Top Prefered Companies To Buy For 2014: Internet Gold Golden Lines Ltd.(IGLD)
Internet Gold ? Golden Lines Ltd., together with its subsidiaries, provides communications services in Israel. The company offers a range of telecommunication operations and services, including domestic fixed-line, cellular and international communication services, multi-channel television, satellite broadcasts, Internet services, customer call centers, maintenance and development of communications infrastructures, provision of communications services to other communications providers, television and radio broadcasts, and supply and maintenance of equipment on customer premises. It also provides data services, server and Web site hosting services, technical maintenance and support services, networking and system services, outsourcing and out-tasking services, security and risk management solutions, and IP based services; media services, which include the sale of advertising on its Web sites; and sale of products and services on the Internet. The company was formerly known as Euronet Golden Lines (1992) Ltd. and changed its name to Internet Gold ? Golden Lines Ltd. in June 1999. The company was founded in 1992 and is headquartered in Ramat Gan, Israel. Internet Gold ? Golden Lines Ltd. is a subsidiary of Eurocom Communications Ltd.
Advisors' Opinion:- [By Garrett Cook]
On Wednesday, the telecommunications services sector proved to be a source of strength for the market. Leading the sector was strength from Internet Gold Golden Lines (NASDAQ: IGLD) and NQ Mobile (NYSE: NQ).
Top Prefered Companies To Buy For 2014: China Natural Resources Inc.(CHNR)
China Natural Resources, Inc., through its subsidiaries, engages in the acquisition and exploitation of mining rights. The company involves in the exploration, extraction, processing, and sale of iron, zinc, and other nonferrous metals extracted or produced at mines primarily located in Anhui Province in the People?s Republic of China. It also involves in the exploration, acquisition, construction, development, and operation of coal mines located in Guizhou Province, the People?s Republic of China. The company is based in Central, Hong Kong.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top decliners in the sector included Arch Coal (NYSE: ACI), off 5.3 percent, and China Natural Resources (NASDAQ: CHNR), down 3.9 percent.
Top Headline
No comments:
Post a Comment